Amos B. Smith

Active 1980–2024

155
Papers
19,697
Citations
91
h-index
150
i10-index

Citations

Citations per year for Amos B. Smith1975: 1 citations1984: 3 citations1985: 2 citations1986: 5 citations1987: 1 citations1988: 1 citations1990: 1 citations1991: 21 citations1992: 50 citations1993: 27 citations1994: 22 citations1995: 13 citations1996: 17 citations1997: 30 citations1998: 19 citations1999: 16 citations2000: 21 citations2001: 58 citations2002: 37 citations2003: 71 citations2004: 55 citations2005: 98 citations2006: 95 citations2007: 68 citations2008: 76 citations2009: 90 citations2010: 84 citations2011: 104 citations2012: 148 citations2013: 130 citations2014: 156 citations2015: 169 citations2016: 179 citations2017: 135 citations2018: 112 citations2019: 439 citations2020: 431 citations2021: 361 citations2022: 272 citations2023: 211 citations2024: 373 citations2025: 113 citations2026: 4 citations1976–1983: no citations, so these years are not shown1989: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,343 citing papers, 33.4% of this breakdownChina: 327 citing papers, 8.1% of this breakdownGermany: 224 citing papers, 5.6% of this breakdownUnited Kingdom: 219 citing papers, 5.4% of this breakdownItaly: 213 citing papers, 5.3% of this breakdownSpain: 159 citing papers, 3.9% of this breakdownIndia: 156 citing papers, 3.9% of this breakdownCanada: 137 citing papers, 3.4% of this breakdownFrance: 121 citing papers, 3% of this breakdownJapan: 96 citing papers, 2.4% of this breakdownAustralia: 85 citing papers, 2.1% of this breakdownSwitzerland: 77 citing papers, 1.9% of this breakdown
0%33.4%Other 21.6%

Fields

  • Medicine30%
  • Chemistry22.7%
  • Biochemistry, Genetics and Molecular Biology21.2%
  • Immunology and Microbiology13%
  • Neuroscience2.5%
  • Pharmacology, Toxicology and Pharmaceutics2.4%
  • Other8.2%

Topics

  • Alzheimer's disease research and treatments4.6%
  • HIV Research and Treatment4.5%
  • Chemical Synthesis and Analysis3.8%
  • Computational Drug Discovery Methods2.5%
  • HIV/AIDS drug development and treatment2.3%
  • Cholinesterase and Neurodegenerative Diseases2.2%
  • Other80.1%

Coauthors

All papers

Open in search
  1. Ibuprofen-like activity in extra-virgin olive oil

    Authors: , , , , , , , , - Nature 2005 cited by 889

  2. Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions

    Authors: , , , , , , , , , , , - Science 2014 cited by 538

  3. Carboxylic Acid (Bio)Isosteres in Drug Design

    Authors: , , - ChemMedChem 2013 cited by 511

  4. Associating HIV-1 envelope glycoprotein structures with states on the virus observed by smFRET

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2019 cited by 217

  5. Structure Property Relationships of Carboxylic Acid Isosteres

    Authors: , , , , , , , , , , , - Journal of Medicinal Chemistry 2016 cited by 284

  6. The Microtubule-Stabilizing Agent, Epothilone D, Reduces Axonal Dysfunction, Neurotoxicity, Cognitive Deficits, and Alzheimer-Like Pathology in an Interventional Study with Aged Tau Transgenic Mice

    Authors: , , , , , , , , , , , - Journal of Neuroscience 2012 cited by 407

  7. Epothilone D Improves Microtubule Density, Axonal Integrity, and Cognition in a Transgenic Mouse Model of Tauopathy

    Authors: , , , , , , , , , , , , - Journal of Neuroscience 2010 cited by 319

  8. Release of gp120 Restraints Leads to an Entry-Competent Intermediate State of the HIV-1 Envelope Glycoproteins

    Authors: , , , , , , , , , , , , - mBio 2016 cited by 173

  9. Microtubule Stabilizing Agents as Potential Treatment for Alzheimer’s Disease and Related Neurodegenerative Tauopathies

    Authors: , , , , , - Journal of Medicinal Chemistry 2012 cited by 210

  10. Peptide/Protein Stapling and Unstapling: Introduction of s -Tetrazine, Photochemical Release, and Regeneration of the Peptide/Protein

    Authors: , - Journal of the American Chemical Society 2015 cited by 187

  11. The β20–β21 of gp120 is a regulatory switch for HIV-1 Env conformational transitions

    Authors: , , , , , , , , , , , , , - Nature Communications 2017 cited by 116

  12. Altered microtubule dynamics in neurodegenerative disease: Therapeutic potential of microtubule-stabilizing drugs

    Authors: , , , , - Neurobiology of Disease 2016 cited by 105

  13. Inhibition of tau fibrillization by oleocanthal via reaction with the amino groups of tau

    Authors: , , , , , - Journal of Neurochemistry 2009 cited by 198

  14. The characterization of microtubule-stabilizing drugs as possible therapeutic agents for Alzheimer's disease and related tauopathies

    Authors: , , , , , , , , , - Pharmacological Research 2010 cited by 161

  15. Cryo-EM structures of HIV-1 trimer bound to CD4-mimetics BNM-III-170 and M48U1 adopt a CD4-bound open conformation

    Authors: , , , , , - Nature Communications 2021 cited by 45

  16. Aminothienopyridazines and Methylene Blue Affect Tau Fibrillization via Cysteine Oxidation

    Authors: , , , , , , - Journal of Biological Chemistry 2013 cited by 147

  17. Unusual Pungency from Extra-Virgin Olive Oil Is Attributable to Restricted Spatial Expression of the Receptor of Oleocanthal

    Authors: , , , , , , , , , - Journal of Neuroscience 2011 cited by 140

  18. Effect of oleocanthal and its derivatives on inflammatory response induced by lipopolysaccharide in a murine chondrocyte cell line

    Authors: , , , , , , , , - Arthritis & Rheumatism 2010 cited by 102

  19. Targeting Vascular and Avascular Compartments of Tumors withC. novyi-NTand Anti-microtubule Agents

    Authors: , , , , , , , , , , , , , , , , - Cancer Biology & Therapy 2004 cited by 97

  20. HIV-1 Vpu restricts Fc-mediated effector functions in vivo

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2022 cited by 30

  21. Alterations in gp120 glycans or the gp41 fusion peptide-proximal region modulate the stability of the human immunodeficiency virus (HIV-1) envelope glycoprotein pretriggered conformation

    Authors: , , , , , , - Journal of Virology 2023 cited by 21

  22. Synthesis and characterization of the fluorescence utility of two Visible-Light-Absorbing tryptophan derivatives

    Authors: , , , - Chemical Physics Letters 2022 cited by 20

  23. Small-molecule inhibitors of HIV-1 entry block receptor-induced conformational changes in the viral envelope glycoproteins

    Authors: , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2004 cited by 255

  24. CD4 mimetics sensitize HIV-1-infected cells to ADCC

    Authors: , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2015 cited by 158